Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive information. Sam Altman hailed the Chinese firm's low-cost AI model as ...